Business Wire (Sat, 29-Aug 6:34 AM ET)
Sanara MedTech Inc. Reports Second Quarter 2026 Financial Results (Unaudited)
Globe Newswire (Tue, 11-Aug 4:10 PM ET)
Are MKTX, SMTI, FBRX, LXFR Obtaining Fair Deals for their Shareholders?
PRNewswire (Thu, 6-Aug 3:48 PM ET)
Globe Newswire (Wed, 5-Aug 3:41 PM ET)
PRNewswire (Wed, 5-Aug 1:26 PM ET)
Globe Newswire (Tue, 4-Aug 2:11 PM ET)
Are MKTX, SMTI, LPSN Obtaining Fair Deals for their Shareholders?
PRNewswire (Mon, 3-Aug 7:38 PM ET)
Business Wire (Mon, 3-Aug 4:19 PM ET)
Globe Newswire (Fri, 31-Jul 8:33 AM ET)
PRNewswire (Thu, 30-Jul 1:16 PM ET)
Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.
Sanara Medtech trades on the NASDAQ stock market under the symbol SMTI.
As of September 9, 2026, SMTI stock price declined to $35.03 with 170,741 million shares trading.
SMTI has a beta of 1.51, meaning it tends to be more sensitive to market movements. SMTI has a correlation of 0.09 to the broad based SPY ETF.
SMTI has a market cap of $322.03 million. This is considered a Small Cap stock.
Last quarter Sanara Medtech reported $28 million in Revenue and -$.05 earnings per share. This fell short of revenue expectation by $-903,243 and met earnings estimates .
In the last 3 years, SMTI traded as high as $43.25 and as low as $16.05.
The top ETF exchange traded funds that SMTI belongs to (by Net Assets): VTI, VXF, FESM, VTWO, AVSC.
SMTI has underperformed the market in the last year with a return of -2.0%, while SPY returned +18.7%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in SMTI shares. However, SMTI has outperformed the market in the last 3 month and 2 week periods, returning +58.6% and +1.0%, while SPY returned +3.4% and -0.5%, respectively. This indicates SMTI has been having a stronger performance recently.
SMTI support price is $34.82 and resistance is $35.28 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SMTI shares will trade within this expected range on the day.